Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007, Article ID 85091, 8 pages
http://dx.doi.org/10.1155/2007/85091
Research Article

Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model

1Drug Safety Research & Development, Pfizer Global Research and Development, 2800 Plymouth Road, Building 50-G0503, Ann Arbor 48105, MI, USA
2Department of Cardiovascular Pharmacology, Pfizer Global Research and Development, 2800 Plymouth Road, Building 50-G0503, Ann Arbor 48105, MI, USA

Received 1 February 2007; Accepted 16 March 2007

Copyright © 2007 Zaher A. Radi and Robert Ostroski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. Brown, “Eplerenone: cardiovascular protection,” Circulation, vol. 107, no. 19, pp. 2512–2518, 2003. View at Publisher · View at Google Scholar · View at PubMed
  2. M. W. Thompson, S. B. Smith, and C. D. Sigmund, “Regulation of human renin mRNA expression and protein release in transgenic mice,” Hypertension, vol. 28, no. 2, pp. 290–296, 1996.
  3. J. L. Lavoie and C. D. Sigmund, “Minireview: overview of the renin-angiotensin system—an endocrine and paracrine system,” Endocrinology, vol. 144, no. 6, pp. 2179–2183, 2003. View at Publisher · View at Google Scholar
  4. M. A. E. Lee, M. Bohm, M. Paul, M. Bader, U. Ganten, and D. Ganten, “Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27,” American Journal of Physiology—Endocrinology and Metabolism, vol. 270, no. 6, pp. E919–E929, 1996.
  5. T. Shimokama, S. Haraoka, H. Horiguchi, F. Sugiyama, K. Murakami, and T. Watanabe, “The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis,” Virchows Archiv, vol. 432, no. 2, pp. 169–175, 1998. View at Publisher · View at Google Scholar
  6. F. Pieruzzi, Z. A. Abassi, and H. R. Keiser, “Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure,” Circulation, vol. 92, no. 10, pp. 3105–3112, 1995.
  7. A. Fukamizu, K. Sugimura, and E. Takimoto et al., “Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes,” Journal of Biological Chemistry, vol. 268, no. 16, pp. 11617–11621, 1993.
  8. T. Kai, S. Shimada, A. Kurooka, T. Takenaka, and K. Ishikawa, “Tissue angiotensin II concentration in the heart and kidneys in transgenic Tsukuba hypertensive mice,” Blood Pressure, vol. 7, no. 1, pp. 61–63, 1998.
  9. R. C. Harris, “Interactions between COX-2 and the renin-angiotensin system in the kidney,” Acta Physiologica Scandinavica, vol. 177, no. 4, pp. 423–427, 2003. View at Publisher · View at Google Scholar
  10. R. C. Harris and M. D. Breyer, “Physiological regulation of cyclooxygenase-2 in the kidney,” American Journal of Physiology—Renal Physiology, vol. 281, no. 1, pp. F1–F11, 2001.
  11. A. Schneider, Y. Zhang, and M. Zhang et al., “Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney,” Kidney International, vol. 65, no. 4, pp. 1205–1213, 2004. View at Publisher · View at Google Scholar · View at PubMed
  12. R. C. Harris, M.-Z. Zhang, and H.-F. Cheng, “Cyclooxygenase-2 and the renal renin-angiotensin system,” Acta Physiologica Scandinavica, vol. 181, no. 4, pp. 543–547, 2004. View at Publisher · View at Google Scholar · View at PubMed
  13. A. Yabuki, M. Matsumoto, R. Kamimura, K. Taniguchi, and S. Suzuki, “Renin, cyclooxygenase-2 and neuronal nitric oxide synthase in the kidneys of transgenic Tsukuba hypertensive mouse,” Experimental Animals, vol. 53, no. 4, pp. 387–390, 2004. View at Publisher · View at Google Scholar
  14. T. Kai, H. Kino, and K. Ishikawa, “Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes,” Hypertension Research, vol. 21, no. 1, pp. 39–46, 1998.
  15. J. Blanco-Rivero, V. Cachofeiro, and V. Lahera et al., “Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats,” Hypertension, vol. 46, no. 1, pp. 107–112, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. J. L. Stock, K. Shinjo, and J. Burkhardt et al., “The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure,” Journal of Clinical Investigation, vol. 107, no. 3, pp. 325–331, 2001.
  17. E. A. Millar, R. M. Angus, G. Hulks, J. J. Morton, J. M. C. Connell, and N. C. Thomson, “Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function,” Thorax, vol. 49, no. 5, pp. 492–495, 1994.
  18. M. D. Breyer, H. R. Jacobson, and R. M. Breyer, “Functional and molecular aspects of renal prostaglandin receptors,” Journal of the American Society of Nephrology, vol. 7, no. 1, pp. 8–17, 1996.
  19. W. L. Smith, R. M. Garavito, and D. L. DeWitt, “Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2,” Journal of Biological Chemistry, vol. 271, no. 52, pp. 33157–33160, 1996. View at Publisher · View at Google Scholar
  20. K. N. M. Khan, C. M. Venturini, and R. T. Bunch et al., “Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity,” Toxicologic Pathology, vol. 26, no. 5, pp. 612–620, 1998.
  21. R. S. Sellers, P. B. Senese, and K. N. M. Khan, “Interspecies differences in the nephrotoxic response to cyclooxygenase inhibition,” Drug and Chemical Toxicology, vol. 27, no. 2, pp. 111–122, 2004. View at Publisher · View at Google Scholar
  22. V. Câmpean, F. Theilg, A. Paliege, M. Breyer, and S. Bachmann, “Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse),” American Journal of Physiology—Renal Physiology, vol. 285, no. 1, pp. F19–F32, 2003.
  23. W. L. Smith and T. G. Bell, “Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex,” American Journal of Physiology—Renal Physiology, vol. 235, no. 5, pp. F451–F457, 1978.
  24. M. G. Currie and P. Needleman, “Renal arachidonic acid metabolism,” Annual Review of Physiology, vol. 46, pp. 327–341, 1984. View at Publisher · View at Google Scholar · View at PubMed
  25. N. Kawada, G. Solis, and N. Ivey et al., “Cyclooxygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction,” Hypertension, vol. 45, no. 6, pp. 1131–1138, 2005. View at Publisher · View at Google Scholar · View at PubMed
  26. T. Okumura, I. Hayashi, and T. Ikezawa et al., “Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension,” Hypertension Research, vol. 25, no. 6, pp. 927–938, 2002. View at Publisher · View at Google Scholar
  27. J. M. Gross, J. E. Dwyer, and F. G. Knox, “Natriuretic response to increased pressure is preserved with COX-2 inhibitors,” Hypertension, vol. 34, no. 5, pp. 1163–1167, 1999.
  28. R. I. Clyman, P. Hardy, and N. Waleh et al., “Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 276, no. 3, pp. R913–R921, 1999.
  29. A.-M. Guerguerian, P. Hardy, and M. Bhattacharya et al., “Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs,” American Journal of Obstetrics and Gynecology, vol. 179, no. 6, pp. 1618–1626, 1998. View at Publisher · View at Google Scholar
  30. A. Koki, K. N. M. Khan, and B. M. Woerner et al., “Cyclooxygenase-2 in human pathological disease,” Advances in Experimental Medicine and Biology, vol. 507, pp. 177–184, 2002.
  31. K. M. Stanfield, R. R. Bell, A. R. Lisowski, M. L. English, S. S. Saldeen, and K. N. M. Khan, “Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy,” Birth Defects Research—Part A: Clinical and Molecular Teratology, vol. 67, no. 1, pp. 54–58, 2003. View at Publisher · View at Google Scholar · View at PubMed
  32. K. M. Stanfield, K. N. M. Khan, and M. R. Gralinski, “Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxen,” Veterinary Immunology and Immunopathology, vol. 80, no. 3-4, pp. 309–314, 2001. View at Publisher · View at Google Scholar
  33. S. Hastürk, B. Kemp, S. K. Kalapurakal, J. M. Kurie, W. K. Hong, and J. S. Lee, “Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma,” Cancer, vol. 94, no. 4, pp. 1023–1031, 2002. View at Publisher · View at Google Scholar · View at PubMed
  34. L. Ermert, M. Ermert, and M. Goppelt-Struebe et al., “Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs,” American Journal of Respiratory Cell and Molecular Biology, vol. 18, no. 4, pp. 479–488, 1998.
  35. M. Murakami, K. Nakashima, and D. Kamei et al., “Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37937–37947, 2003. View at Publisher · View at Google Scholar · View at PubMed
  36. Y. Guan, Y. Zhang, and A. Schneider et al., “Urogenital distribution of a mouse membrane-associated prostaglandin E2 synthase,” American Journal of Physiology—Renal Physiology, vol. 281, no. 6, pp. F1173–F1177, 2001.
  37. G. Giannico, M. Mendez, and M. C. LaPointe, “Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 1, pp. H165–H174, 2005. View at Publisher · View at Google Scholar · View at PubMed
  38. J. E. Dinchuk, B. D. Car, and R. J. Focht et al., “Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II,” Nature, vol. 378, no. 6555, pp. 406–409, 1995. View at Publisher · View at Google Scholar · View at PubMed
  39. S. G. Morham, R. Langenbach, and C. D. Loftin et al., “Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse,” Cell, vol. 83, no. 3, pp. 473–482, 1995. View at Publisher · View at Google Scholar
  40. J. Schnermann, “Cyclooxygenase-2 and macula densa control of renin secretion,” Nephrology Dialysis Transplantation, vol. 16, no. 9, pp. 1735–1738, 2001. View at Publisher · View at Google Scholar
  41. E. K. Jackson, J. A. Oates, and R. A. Branch, “Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation,” Circulation Research, vol. 49, no. 1, pp. 180–185, 1981.
  42. J.-L. Wang, H.-F. Cheng, and R. C. Harris, “Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension,” Hypertension, vol. 34, no. 1, pp. 96–101, 1999.
  43. T. Yang, Y. Endo, Y. G. Huang, A. Smart, J. P. Briggs, and J. Schnermann, “Renin expression in COX-2-knockout mice on normal or low-salt diets,” American Journal of Physiology—Renal Physiology, vol. 279, no. 5, pp. F819–F825, 2000.
  44. H. Takizawa, “Airway epithelial cells as regulators of airway inflammation (review),” International Journal of Molecular Medicine, vol. 1, no. 2, pp. 367–378, 1998.
  45. V. J. Dzau, G. H. Gibbons, and R. E. Pratt, “Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia,” Hypertension, vol. 18, no. 4, supplement 2, pp. 100–105, 1991.
  46. M. D. Breyer and R. C. Harris, “Cyclooxygenase 2 and the kidney,” Current Opinion in Nephrology & Hypertension, vol. 10, no. 1, pp. 89–98, 2001. View at Publisher · View at Google Scholar
  47. A. V. Sampey, S. Monrad, and L. J. Crofford, “Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2,” Arthritis Research and Therapy, vol. 7, no. 3, pp. 114–117, 2005. View at Publisher · View at Google Scholar · View at PubMed
  48. M. Kömhoff, S. C. Reinalter, H. J. Gröne, and H. W. Seyberth, “Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies,” Pediatric Research, vol. 55, no. 2, pp. 261–266, 2004.